SanReno Therapeutics, founded in December 2021, is a clinical-stage biotech company with a focus on kidney diseases and related therapeutic areas. The company is dedicated to research and development, production, and commercialization of drugs to address kidney diseases, aiming to provide innovative clinical solutions to improve the lives of patients. SanReno's current portfolio includes two core assets, atrasentan in Phase II...
SanReno Therapeutics, founded in December 2021, is a clinical-stage biotech company with a focus on kidney diseases and related therapeutic areas. The company is dedicated to research and development, production, and commercialization of drugs to address kidney diseases, aiming to provide innovative clinical solutions to improve the lives of patients. SanReno's current portfolio includes two core assets, atrasentan in Phase III and BION-1301 in Phase II, with operations in the Greater China area and Singapore.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.